Literature DB >> 6171995

Beta 2-microglobulin serum levels in infectious mononucleosis in childhood.

K K Ibsen, S Krabbe, J Hesse.   

Abstract

A material of fifteen children aged 10 months to 15 years with infectious mononucleosis (IM) was investigated. The diagnosis was established by demonstration of Epstein-Barr virus (EBV) specific IgM antibodies. The serum concentrations of beta 2-microglobulin (beta 2-m) were significantly increased (p less than 0.01) in the first sample after onset of disease, compared to control groups of children with other infectious diseases and children without diseases. The serum concentration of beta 2-m decreased towards normal range within 3 weeks- 3 months. During the same period, IgM antibodies of EBV decreased to unmeasurable levels, and the IgG titers were almost constant. Serum beta -2m may be a parameter of value in the diagnosis of infectious mononucleosis in childhood, replacing tests for heterophile antibodies (Emni test and Paul-Bunnell test) which are often negative in children suffering from a primary EBV infection, or it may be used for assessment of disease activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171995     DOI: 10.1111/j.1699-0463.1981.tb02687.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  3 in total

1.  Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.

Authors:  B Hofmann; H Bass; P Nishanian; M Faisal; R A Figlin; G P Sarna; J L Fahey
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

2.  Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.

Authors:  E H Cooper; M A Forbes; M H Hambling
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

3.  High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis.

Authors:  Ewelina Grywalska; Jacek Roliński; Marcin Pasiarski; Izabela Korona-Glowniak; Maciej Maj; Agata Surdacka; Agnieszka Grafka; Agnieszka Stelmach-Gołdyś; Michał Zgurski; Stanisław Góźdź; Anna Malm; Piotr Grabarczyk; Elżbieta Starosławska
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.